Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Albaha Barqawi

Concepts (147)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prostatic Neoplasms
14
2021
1010
1.950
Why?
Cryotherapy
3
2021
16
1.780
Why?
Prostate
3
2020
177
0.740
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2021
147
0.680
Why?
Imaging, Three-Dimensional
2
2020
534
0.590
Why?
Neoplasm Recurrence, Local
1
2020
957
0.460
Why?
Lower Urinary Tract Symptoms
1
2013
54
0.400
Why?
Symptom Assessment
1
2013
125
0.400
Why?
Ultrasound, High-Intensity Focused, Transrectal
1
2011
2
0.370
Why?
Prostate-Specific Antigen
6
2020
160
0.320
Why?
Ultrasonography, Interventional
2
2020
127
0.230
Why?
Self Medication
1
2004
10
0.230
Why?
Prazosin
1
2004
24
0.220
Why?
Plant Preparations
1
2004
31
0.220
Why?
Prostatic Hyperplasia
1
2004
42
0.220
Why?
Palpation
1
2003
11
0.220
Why?
Phytotherapy
1
2004
76
0.210
Why?
Cryptorchidism
1
2003
12
0.210
Why?
Anticarcinogenic Agents
1
2004
77
0.210
Why?
Complementary Therapies
1
2004
86
0.210
Why?
Testis
1
2003
144
0.200
Why?
Vitamins
1
2004
172
0.200
Why?
Combined Modality Therapy
2
2021
1209
0.190
Why?
Adenocarcinoma
2
2007
888
0.180
Why?
Neoplasm Staging
1
2004
1288
0.180
Why?
Kallikreins
1
2020
29
0.170
Why?
Image-Guided Biopsy
1
2020
37
0.170
Why?
Urination Disorders
2
2013
13
0.170
Why?
Dietary Supplements
1
2004
529
0.160
Why?
Male
17
2021
62883
0.160
Why?
Laparoscopy
1
2003
454
0.150
Why?
Middle Aged
9
2021
30893
0.140
Why?
Survival Rate
1
2021
1872
0.130
Why?
Mass Screening
1
2004
1152
0.130
Why?
Aged
8
2020
21971
0.130
Why?
Pilot Projects
1
2021
1558
0.130
Why?
Prospective Studies
2
2021
7043
0.120
Why?
Andropause
1
2013
5
0.110
Why?
Nocturia
1
2013
8
0.110
Why?
Antineoplastic Agents, Hormonal
2
2005
158
0.110
Why?
Humans
18
2021
128524
0.110
Why?
Case-Control Studies
1
2021
3326
0.110
Why?
Urology
1
2013
58
0.100
Why?
Dexamethasone
2
2006
336
0.100
Why?
Prognosis
1
2021
3780
0.100
Why?
Biopsy
2
2007
1085
0.100
Why?
Testosterone
2
2013
378
0.100
Why?
Follow-Up Studies
1
2021
4898
0.090
Why?
Quality of Life
2
2020
2680
0.080
Why?
Societies, Medical
1
2013
749
0.080
Why?
Retrospective Studies
4
2020
14460
0.080
Why?
Treatment Outcome
3
2020
10163
0.070
Why?
Androgen Antagonists
2
2006
78
0.070
Why?
Biopsy, Needle
1
2008
189
0.070
Why?
Patient Selection
1
2011
661
0.070
Why?
Prostatectomy
1
2007
105
0.070
Why?
Cryosurgery
1
2007
54
0.060
Why?
Myocardial Infarction
1
2013
1014
0.060
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2006
1565
0.060
Why?
Carboplatin
1
2006
139
0.060
Why?
Minimally Invasive Surgical Procedures
1
2007
172
0.060
Why?
Severity of Illness Index
1
2013
2736
0.060
Why?
Stroke
1
2013
1064
0.060
Why?
Orchiectomy
1
2005
65
0.060
Why?
Doxazosin
1
2004
3
0.060
Why?
Penile Erection
1
2004
7
0.060
Why?
Adrenergic alpha-Antagonists
1
2004
32
0.060
Why?
Finasteride
1
2004
37
0.060
Why?
Prostaglandin-Endoperoxide Synthases
1
2004
73
0.060
Why?
Selenium
1
2004
36
0.060
Why?
Early Diagnosis
1
2005
236
0.050
Why?
Vas Deferens
1
2003
12
0.050
Why?
Seminal Vesicles
1
2003
9
0.050
Why?
Inguinal Canal
1
2003
10
0.050
Why?
Peritoneal Cavity
1
2003
30
0.050
Why?
Patient Care Planning
1
2004
148
0.050
Why?
Gastroschisis
1
2003
21
0.050
Why?
Seminoma
1
2003
17
0.050
Why?
Anus, Imperforate
1
2003
24
0.050
Why?
Radiation Injuries
1
2004
137
0.050
Why?
Cyclooxygenase 2
1
2004
172
0.050
Why?
Forecasting
1
2005
358
0.050
Why?
Cyclophosphamide
1
2003
231
0.050
Why?
Isoenzymes
1
2004
304
0.050
Why?
Drug Utilization
1
2004
167
0.050
Why?
Hypospadias
1
2003
28
0.050
Why?
Ultrasonography
1
2007
723
0.050
Why?
Vitamin D
1
2006
381
0.050
Why?
Chromosome Aberrations
1
2003
147
0.050
Why?
Carcinoma
1
2004
214
0.050
Why?
United States
2
2013
13876
0.050
Why?
Testicular Neoplasms
1
2003
102
0.050
Why?
Urinary Bladder, Neurogenic
1
2002
35
0.050
Why?
Health Surveys
1
2004
492
0.050
Why?
Aged, 80 and over
3
2007
7040
0.040
Why?
Antioxidants
1
2004
543
0.040
Why?
Sulfonamides
1
2004
500
0.040
Why?
Socioeconomic Factors
1
2004
1197
0.040
Why?
Family
1
2004
642
0.040
Why?
Randomized Controlled Trials as Topic
1
2004
1358
0.040
Why?
Adult
3
2007
35315
0.040
Why?
Antibodies, Monoclonal
1
2004
1355
0.040
Why?
Research Design
1
2004
1038
0.040
Why?
Membrane Proteins
1
2004
1108
0.040
Why?
Oxidative Stress
1
2004
1188
0.040
Why?
Colorado
1
2004
4392
0.030
Why?
Antineoplastic Agents
1
2004
2058
0.030
Why?
Coronary Angiography
1
2013
306
0.020
Why?
Mortality
1
2013
307
0.020
Why?
Surveys and Questionnaires
1
2004
5346
0.020
Why?
Risk
1
2013
852
0.020
Why?
Risk Factors
1
2004
9727
0.020
Why?
Infant
1
2003
8913
0.020
Why?
Child, Preschool
1
2003
10373
0.020
Why?
Coronary Artery Disease
1
2013
677
0.020
Why?
Medical History Taking
1
2007
115
0.020
Why?
Child
2
2003
20721
0.020
Why?
Syndrome
1
2007
335
0.020
Why?
Image Interpretation, Computer-Assisted
1
2008
254
0.020
Why?
Pedigree
1
2007
485
0.020
Why?
Gynecomastia
1
2005
6
0.020
Why?
Sexual Dysfunction, Physiological
1
2005
67
0.010
Why?
Muscular Diseases
1
2005
110
0.010
Why?
Hot Flashes
1
2005
81
0.010
Why?
Trastuzumab
1
2004
100
0.010
Why?
Adolescent
1
2003
20213
0.010
Why?
Anemia
1
2005
156
0.010
Why?
Infusions, Intravenous
1
2004
384
0.010
Why?
In Situ Hybridization, Fluorescence
1
2004
313
0.010
Why?
Cohort Studies
1
2013
5369
0.010
Why?
Gastrointestinal Diseases
1
2005
197
0.010
Why?
Bladder Exstrophy
1
2002
16
0.010
Why?
Cystostomy
1
2002
9
0.010
Why?
Osteoporosis
1
2005
233
0.010
Why?
Receptor, ErbB-2
1
2004
336
0.010
Why?
Veterans
1
2013
1414
0.010
Why?
Animals
1
2004
34501
0.010
Why?
Urethra
1
2002
52
0.010
Why?
Neural Tube Defects
1
2002
62
0.010
Why?
Transplantation, Autologous
1
2002
215
0.010
Why?
Body Composition
1
2005
656
0.010
Why?
Spinal Dysraphism
1
2002
67
0.010
Why?
Immunohistochemistry
1
2004
1669
0.010
Why?
Drug Resistance, Neoplasm
1
2004
749
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2004
759
0.010
Why?
Disease Progression
1
2004
2603
0.010
Why?
Mental Disorders
1
2005
1007
0.010
Why?
Barqawi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)